Publication

Barriers and facilitators to conduct high-quality, large-scale safety and comparative effectiveness research: The Biologics and Biosimilars Collective Intelligence Consortium experience.

August 11, 2019
Authors:

Lockhart CM, McDermott CL, Felix T, Lin ND, Cziraky MJ, Mendelsohn AB, Brown JS

Expertise:
RWE Research & Consulting

Published in Pharmacoepidemiology & Drug Safety

Access on PubMed